메뉴 건너뛰기




Volumn 6, Issue 5, 1999, Pages 412-419

Use of meta-analytic results to facilitate shared decision making

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TERAZOSIN;

EID: 0032887271     PISSN: 10675027     EISSN: None     Source Type: Journal    
DOI: 10.1136/jamia.1999.0060412     Document Type: Article
Times cited : (30)

References (20)
  • 1
    • 0028887712 scopus 로고
    • Benign prostatic hyperplasia: Medical and minimally invasive treatment options
    • Oesterling J. Benign prostatic hyperplasia: medical and minimally invasive treatment options. N Engl J Med. 1995;332: 99-109.
    • (1995) N Engl J Med. , vol.332 , pp. 99-109
    • Oesterling, J.1
  • 2
    • 0017076325 scopus 로고
    • The use of alpha adrenergic blockers in benign prostatic obstruction
    • Caine M, Pfau A, Perlberg S. The use of alpha adrenergic blockers in benign prostatic obstruction. Br J Urol. 1976;48: 255-64.
    • (1976) Br J Urol. , vol.48 , pp. 255-264
    • Caine, M.1    Pfau, A.2    Perlberg, S.3
  • 3
    • 0017040902 scopus 로고
    • A new look at bladder neck obstruction by the food and drug administration regulators: Guidelines for investigation of benign prostatic hypertrophy
    • Boyarsky S, Jones G, Paulson DF, Prout GRJ. A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg. 1976;68:29-32.
    • (1976) Trans Am Assoc Genitourin Surg. , vol.68 , pp. 29-32
    • Boyarsky, S.1    Jones, G.2    Paulson, D.F.3    Prout, G.R.J.4
  • 4
    • 0026591918 scopus 로고
    • The american urological association symptom index for benign prostatic hyperplasia
    • Measurement Committee of the American Urological Association discussion 1564
    • Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. Measurement Committee of the American Urological Association. J Urol. 1992;148:1549-57; discussion 1564.
    • (1992) J Urol. , vol.148 , pp. 1549-1557
    • Barry, M.J.1    Fowler F.J., Jr.2    O'Leary, M.P.3
  • 5
    • 0026526408 scopus 로고
    • Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine medical assessment program symptom indexes
    • Measurement Committee of the American Urological Association discussion 1564
    • Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. J Urol. 1992;148:1558-63; discussion 1564.
    • (1992) J Urol. , vol.148 , pp. 1558-1563
    • Barry, M.J.1    Fowler F.J., Jr.2    O'Leary, M.P.3    Bruskewitz, R.C.4    Holtgrewe, H.L.5    Mebust, W.K.6
  • 6
    • 0027283961 scopus 로고
    • Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia
    • Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 1993;150:351-8.
    • (1993) J Urol. , vol.150 , pp. 351-358
    • Barry, M.J.1    Cockett, A.T.2    Holtgrewe, H.L.3    McConnell, J.D.4    Sihelnik, S.A.5    Winfield, H.N.6
  • 7
    • 0029939081 scopus 로고    scopus 로고
    • The hytrin community assessment trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia
    • Roehrborn CG, Oesterling JE, Auerbach S, Kaplan SA. The Hytrin community assessment trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. Urology. 1996; 47:159-68.
    • (1996) Urology. , vol.47 , pp. 159-168
    • Roehrborn, C.G.1    Oesterling, J.E.2    Auerbach, S.3    Kaplan, S.A.4
  • 8
    • 0028023946 scopus 로고
    • Terazosin in the treatment of hypertension and symptomatic benign prostatic hyperplasia: A primary care trial
    • Guthrie R. Terazosin in the treatment of hypertension and symptomatic benign prostatic hyperplasia: a primary care trial. J Fam Pract. 1994;39:129-33.
    • (1994) J Fam Pract. , vol.39 , pp. 129-133
    • Guthrie, R.1
  • 9
    • 0030248565 scopus 로고    scopus 로고
    • Safety and efficacy of doxazosin in benign prostatic hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies
    • Roehrborn CG, Siegel RL. Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. Urology. 1996;48: 406-15.
    • (1996) Urology. , vol.48 , pp. 406-415
    • Roehrborn, C.G.1    Siegel, R.L.2
  • 11
    • 85047690119 scopus 로고
    • Terazosin in the treatment of benign prostatic hyperplasia
    • Terazosin Benign Prostatic Hyperplasia Study Group
    • Brawer MK, Adams G, Epstein H. Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study Group. Arch Fam Med. 1993;2: 929-35.
    • (1993) Arch Fam Med. , vol.2 , pp. 929-935
    • Brawer, M.K.1    Adams, G.2    Epstein, H.3
  • 12
    • 0026460119 scopus 로고
    • Use of terazosin in the medical treatment of benign prostatic hyperplasia: Experience in Italy
    • Di Silverio F. Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience in Italy. Br J Urol. 1992;70(suppl 1): 22-6.
    • (1992) Br J Urol. , vol.70 , Issue.SUPPL. 1 , pp. 22-26
    • Di Silverio, F.1
  • 13
    • 9044220970 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia
    • Elhilali MM, Ramsey EW, Barkin J, et al. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia. Urology. 1996;47:335-42.
    • (1996) Urology. , vol.47 , pp. 335-342
    • Elhilali, M.M.1    Ramsey, E.W.2    Barkin, J.3
  • 14
    • 0026574697 scopus 로고
    • A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia
    • Lepor H, Auerbach S, Puras-Baez A, et al. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol. 1992;148:1467-74.
    • (1992) J Urol. , vol.148 , pp. 1467-1474
    • Lepor, H.1    Auerbach, S.2    Puras-Baez, A.3
  • 15
    • 9444268678 scopus 로고    scopus 로고
    • The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
    • Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group
    • Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med. 1996;335:533-9.
    • (1996) N Engl J Med. , vol.335 , pp. 533-539
    • Lepor, H.1    Williford, W.O.2    Barry, M.J.3
  • 16
    • 0026488344 scopus 로고
    • Terazosin in the treatment of benign prostatic hyperplasia: A multicentre, placebo-controlled trial
    • Lloyd SN, Buckley JF, Chilton CP, Ibrahim I, Kaisary AV, Kirk D. Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial. Br J Urol. 1992;70(suppl 1):17-21.
    • (1992) Br J Urol. , vol.70 , Issue.SUPPL. 1 , pp. 17-21
    • Lloyd, S.N.1    Buckley, J.F.2    Chilton, C.P.3    Ibrahim, I.4    Kaisary, A.V.5    Kirk, D.6
  • 17
    • 4243512170 scopus 로고
    • Terazosin for the treatment of benign prostatic hyperplasia in the elderly: A 6-month double-blind study
    • Soloway M, Snyder J, Stone N, Laddu A. Terazosin for the treatment of benign prostatic hyperplasia in the elderly: a 6-month double-blind study. J Am Geriatr Soc. 1992;40: SA11.
    • (1992) J Am Geriatr Soc. , vol.40
    • Soloway, M.1    Snyder, J.2    Stone, N.3    Laddu, A.4
  • 18
    • 0028865153 scopus 로고
    • Benign prostatic hyperplasia specific health status measures in clinical research: How much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?
    • Barry MJ, Williford WO, Chang Y, et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol. 1995; 154:1770-4.
    • (1995) J Urol. , vol.154 , pp. 1770-1774
    • Barry, M.J.1    Williford, W.O.2    Chang, Y.3
  • 20
    • 0028816195 scopus 로고
    • A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia
    • Wasson JH, Reda DJ, Bruskewitz RG, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med. 1995;332:75-9.
    • (1995) N Engl J Med. , vol.332 , pp. 75-79
    • Wasson, J.H.1    Reda, D.J.2    Bruskewitz, R.G.3    Elinson, J.4    Keller, A.M.5    Henderson, W.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.